Literature DB >> 25424203

Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus.

Lorna J Dunn1, Janusz A Jankowski, S Michael Griffin.   

Abstract

BACKGROUND: Trefoil proteins are believed to have an important role in mucosal protection and repair in the gastrointestinal tract. They are well recognized in Barrett's esophagus and considered a potential biomarker for the condition. Metaplasia occurring in the esophageal remnant after esophagectomy is a human model for the early stages of development of Barrett's esophagus. AIMS: To assess expression of trefoil proteins in post-esophagectomy columnar epithelium and to use trefoils as a molecular tool to understand regenerative mucosa in the esophagus.
METHODS: Patients with columnar metaplasia in the esophageal remnant were recruited from a large esophago-gastric cancer center. Trefoil factor expression was determined using immunohistochemical techniques.
RESULTS: Samples were obtained from 37 patients. TFF1 and TFF2 were expressed by all samples in a similar pattern to that described in studies of sporadic Barrett's esophagus. TFF3 was less widely expressed and was significantly associated with time elapsed between surgery and endoscopy. Median time from surgery to endoscopy was 8.1 years for patients with TFF3 expression versus 3.4 years for those without (p = 0.004).
CONCLUSIONS: Widespread expression of trefoils in this environment suggests that these proteins have an important role in development of Barrett's metaplasia. TFF3 expression may be absent in the early stages of metaplasia and may represent more established columnar epithelium. Biopsy samples from post-esophagectomy patients provide a valuable resource to study the early stages of Barrett's esophagus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25424203     DOI: 10.1007/s10620-014-3440-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

Review 1.  Trefoil factors: from ulceration to neoplasia.

Authors:  G Regalo; N A Wright; J C Machado
Journal:  Cell Mol Life Sci       Date:  2005-12       Impact factor: 9.261

Review 2.  The trefoil factor family - small peptides with multiple functionalities.

Authors:  S Kjellev
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

3.  hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus.

Authors:  F Hauser; R Poulsom; R Chinery; L A Rogers; A M Hanby; N A Wright; W Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

4.  Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa.

Authors:  R J Longman; J Douthwaite; P A Sylvester; R Poulsom; A P Corfield; M G Thomas; N A Wright
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration.

Authors:  R J Playford; T Marchbank; R Chinery; R Evison; M Pignatelli; R A Boulton; L Thim; A M Hanby
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

6.  Continuing rapid increase in esophageal adenocarcinoma in England and Wales.

Authors:  Côme Lepage; Bernard Rachet; Valérie Jooste; Jean Faivre; Michel P Coleman
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

7.  Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein.

Authors:  O Lefebvre; M P Chenard; R Masson; J Linares; A Dierich; M LeMeur; C Wendling; C Tomasetto; P Chambon; M C Rio
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

8.  Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells.

Authors:  N A Wright; C Pike; G Elia
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

9.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.

Authors:  A Dignass; K Lynch-Devaney; H Kindon; L Thim; D K Podolsky
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands.

Authors:  Danielle L Lavery; Anna M Nicholson; Richard Poulsom; Rosemary Jeffery; Alia Hussain; Laura J Gay; Janusz A Jankowski; Sebastian S Zeki; Hugh Barr; Rebecca Harrison; James Going; Sritharan Kadirkamanathan; Peter Davis; Timothy Underwood; Marco R Novelli; Manuel Rodriguez-Justo; Neil Shepherd; Marnix Jansen; Nicholas A Wright; Stuart A C McDonald
Journal:  Gut       Date:  2014-02-18       Impact factor: 23.059

  10 in total
  3 in total

1.  Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study.

Authors:  Zhixiong Wang; Swetha Kambhampati; Yulan Cheng; Ke Ma; Cem Simsek; Alan H Tieu; John M Abraham; Xi Liu; Vishnu Prasath; Mark Duncan; Alejandro Stark; Alexander Trick; Hua-Ling Tsai; Hao Wang; Yulong He; Mouen A Khashab; Saowanee Ngamruengphong; Eun J Shin; Tza-Huei Wang; Stephen J Meltzer
Journal:  Clin Cancer Res       Date:  2019-01-22       Impact factor: 13.801

2.  Individual patient oesophageal cancer 3D models for tailored treatment.

Authors:  John H Saunders; David Onion; Pamela Collier; Matthew S Dorrington; Richard H Argent; Philip A Clarke; Alex M Reece-Smith; Simon L Parsons; Anna M Grabowska
Journal:  Oncotarget       Date:  2017-04-11

3.  Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer.

Authors:  Hui Xie; Jian-Hai Guo; Wei-Min An; Sheng-Tao Tian; Hai-Peng Yu; Xue-Ling Yang; Hua-Ming Wang; Zhi Guo
Journal:  World J Gastroenterol       Date:  2017-03-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.